IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that ...
SUMMIT, N.J., Jan. 13, 2025 /PRNewswire/ -- Vascarta has obtained the exclusive rights to a novel method of creating more effective cancer therapies with fewer side effects applying new and unique ...
The addition of camrelizumab to platinum-containing intensive chemotherapy improved response ... also exhibited a manageable safety profile, according to investigators. Data derived from Shao ...
In view of this centennial, and the current stagnation in antibacterial pipelines, it seems timely to reflect on the ground-breaking contributions of Ehrlich to the birth of chemotherapy (see Ref.